Co announces that it and its subsidiary Mylan Pharmaceuticals have entered into a patent license and settlement agreement with GlaxoSmithKline (GSK) relating to Paroxetine Hydrochloride Extended ...

GSK Plc said on Monday its HIV-focused unit ViiV Healthcare's cabotegravir long-acting injectable and tablets had received a recommendation for marketing authorisation from the European Medicines ...

The drug is the generic version of GlaxoSmithKline’s Ceftin, which has annual sales of $28.7 million, according to research firm IMS Health of Norwalk, Conn.